Literature DB >> 22607045

Coronary artery bypass grafting for myocardial bridges of the left anterior descending artery.

Xiaoning Sun1, Hao Chen, Limin Xia, Dong Zhao, Wenjun Ding, Chunsheng Wang.   

Abstract

BACKGROUND AND AIM OF THE STUDY: There is still controversy with regard to adequate therapy for symptomatic patients who are refractory to medical management with myocardial bridges of the left anterior descending artery. This study sought to evaluate the treatment of symptomatic coronary myocardial bridges with coronary artery bypass graft surgery.
METHODS: Thirteen patients who underwent surgery between October 2005 and May 2008 were included in this study. The mean patient age was 51.3 ± 10.2 years (range, 39-75 years). There were ten men and three women. All 13 patients had angina pectoris preoperatively, and they had myocardial bridges only. Coronary angiography prior to surgery demonstrated myocardial bridging of the left anterior descending artery with systolic compression ≥75% in all patients. They underwent off-pump coronary artery bypass grafting using the internal mammary artery.
RESULTS: The acute clinical success rate was 100% with respect to the absence of myocardial infarction, death, or other major in-hospital complications. Postoperative coronary CT angiography studies in seven patients after one year demonstrated no graft stenosis. During follow-up, no patient had symptoms of angina.
CONCLUSIONS: Coronary artery bypass graft surgery using a LIMA graft is a safe and effective treatment for symptomatic coronary myocardial bridges.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22607045     DOI: 10.1111/j.1540-8191.2012.01457.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  8 in total

1.  Myocardial bridging: what have we learned in the past and will new diagnostic modalities provide new insights?

Authors:  A V G Bruschke; C E Veltman; M A de Graaf; H W Vliegen
Journal:  Neth Heart J       Date:  2013-01       Impact factor: 2.380

2.  Myocardial bridging with left ventricular hypertrophy presenting as Wellens pattern.

Authors:  Ahmad Abuarqoub; Maria Naranjo; Fayez Shamoon
Journal:  Ann Transl Med       Date:  2017-10

Review 3.  Myocardial bridging: contemporary understanding of pathophysiology with implications for diagnostic and therapeutic strategies.

Authors:  Michel T Corban; Olivia Y Hung; Parham Eshtehardi; Emad Rasoul-Arzrumly; Michael McDaniel; Girum Mekonnen; Lucas H Timmins; Jerre Lutz; Robert A Guyton; Habib Samady
Journal:  J Am Coll Cardiol       Date:  2014-02-26       Impact factor: 24.094

Review 4.  Is coronary artery bypass grafting an acceptable alternative to myotomy for the treatment of myocardial bridging?

Authors:  Saina Attaran; Marco Moscarelli; Thanos Athanasiou; Jon Anderson
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-11-21

Review 5.  The Myocardial Bridge: Potential Influences on the Coronary Artery Vasculature.

Authors:  Hiroki Teragawa; Chikage Oshita; Tomohiro Ueda
Journal:  Clin Med Insights Cardiol       Date:  2019-05-01

6.  Combined Myocardial Bridge and Coronary Vessel Disease Requiring Coronary Artery Bypass Grafting and Myotomy of the Myocardial Bridge.

Authors:  Mohammed Al-Musawi; Amanda Marsh; Slee Yi; Suhad AlOmaishi; David Rubay
Journal:  Cureus       Date:  2019-12-28

7.  Minimally invasive coronary artery bypass grafting via a lower ministernotomy for left anterior descending artery myocardial bridging: mid-term results.

Authors:  Ahmed Ghazy; Hesham Alkady; Ahmad Abugameh; Katja Buschmann; Rayan Chaban; Nalan Schnelle; Angela Kornberger; Andres Beiras-Fernandez; C-F Vahl
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-07-26

8.  Recurrent attack of acute myocardial infarction complicated with ventricular fibrillation due to coronary vasospasm within a myocardial bridge: a case report.

Authors:  Xingwei He; Zakarya Ahmed; Xin Liu; Chang Xu; Hesong Zeng
Journal:  BMC Cardiovasc Disord       Date:  2020-08-24       Impact factor: 2.298

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.